Loading clinical trials...
Loading clinical trials...
The aim of the current study is to assess the desensitising effect of nanosilver fluoride on first permanent molars (FPMs) in patients with MIH in comparison to low-level laser therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alexandria University
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT06406114 · Drug Allergy, Cephalosporin Allergy, and more
NCT07069127 · Celiac Disease, Dentin Hypersensitivity, and more
NCT07215767 · Dentin Hypersensitivity
NCT07352813 · Molar Incisor Hypomineralization, Hypersensitivity
Faculty of Dentistry, Alexandria University
Alexandria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions